Us2.ai, a leader in AI-automated echocardiography solutions and Advara HeartCare, the largest provider of cardiac healthcare services in Australia, are excited to announce a pilot aimed at enhancing heart disease detection, diagnosis and treatment.

This pilot brings Us2.ai’s cutting-edge AI automated echocardiography solution to TickerCardiology, Advara HeartCare’s echocardiogram PACS software, to enhance the delivery of accurate, efficient, and personalised cardiovascular care. By integrating Us2.ai’s innovative AI-driven solutions into Advara HeartCare’s clinical practices, the partnership seeks to improve patient outcomes and streamline the diagnostic process.

Key Highlights:

1. Enhanced Diagnostic Accuracy: Us2.ai’s advanced solution will, over time, use AI to support Advara HeartCare’s cardiologists in analysing echocardiograms with greater precision. This will facilitate early detection and accurate diagnosis of various cardiovascular conditions, enabling timely and effective treatment.
2. Increased Efficiency: The integration of AI cloud technology is expected to significantly reduce the time required for echocardiogram analysis. This efficiency gain will lead to faster diagnosis and treatment, improving the overall patient experience.
3. Personalized Treatment Plans: Leveraging AI insights, Advara HeartCare can offer more tailored treatment plans for patients. The AI-driven analysis provides detailed information that supports the design of personalised care strategies, enhancing the effectiveness of interventions and improving patient outcomes.
4. Research and Development: Us2.ai and Advara HeartCare also intend to collaborate on further research in the field of cardiology, to enable further enhancements to the diagnostic process.

Quotes from Leadership:

“We are proud to partner with Advara HeartCare and bring our AI solution into their clinical settings,” said Daniel Ishak, Commercial Director of Us2.ai. “This collaboration is another significant step forward in our mission to transform cardiovascular care.”

“At Advara HeartCare we are committed to improving Australia’s Heart Health. Whilst our clinical teams remain the focus (or at the heart) of our patients’ care, partnering with US2Ai we are excited to investigate how AI can enhance our diagnostic capabilities and optimize the experience and clinical outcomes for our patients.” said Dr Daniel Cehic, Chief Medical Officer and Dr David O’Donnell, Chief Executive Officer of Advara HeartCare.

About Us2.ai

Us2.ai is a pioneer in the development of AI technology for cardiovascular care. The company’s mission is to leverage advanced AI algorithms to assist healthcare professionals in diagnosing and treating heart disease more accurately and efficiently. Us2.ai’s solutions are designed to integrate seamlessly into clinical workflows, providing valuable insights that improve patient care and outcomes.

About Advara HeartCare

Advara HeartCare is the largest cardiology provider in Australia, with 1.5 million patient interactions annually delivered by over 100 cardiologists across 70 centres throughout metro and regional locations. At Advara HeartCare we believe we can optimize the delivery of high-quality care by integrating state-of-the-art technology with our exceptional clinical teams. Advara HeartCare offers a full spectrum of cardiology services, including diagnostic testing, treatment, and ongoing management of heart conditions, as well as the TickerCardiology platforms.